Cardiorostin FB 160mg/10mg Tablet
In Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Cardiorostin FB 160mg/10mg Tablet also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Cardiorostin FB 160mg/10mg Tablet
Cardiorostin FB 160mg/10mg Tablet is a combination of medicines which together reduces lipid content in the blood. It is used to lower the cholesterol and triglycerides level in the body and reduces the risk of heart related disease.
How Cardiorostin FB 160mg/10mg Tablet works
Cardiorostin FB 160mg/10mg Tablet is a mix of two medicines that team up to keep your blood lipids in check. Fenofibrate tackles triglycerides, a type of fat in your blood, while Rosuvastatin blocks the creation of bad cholesterol (LDL). They also help increase the levels of good cholesterol (HDL). By working together, these medications help maintain a balanced and healthier mix of fats in your blood, supporting overall heart health.
How To Use Cardiorostin FB 160mg/10mg Tablet
- Follow your doctor's guidance for this medicine, taking it in the prescribed dose and duration.
- You can take this medicine with meals or before it, but maintain a consistency in time is recommended for better results.
- Swallow the drug without chewing, crushing, or breaking it.
Special Precautions for Cardiorostin FB 160mg/10mg Tablet
- Both fenofibrate and rosuvastatin have been associated with muscle related side effects, including myopathy and rhabdomyolysis (a severe condition involving muscle breakdown). Combining these medications may increase the risk of muscle related adverse effects. It's essential to report any unexplained muscle pain, weakness, or tenderness promptly to your healthcare provider.
- Both medications can affect liver function, and combining them may increase the risk of liver related complications. Regular liver function tests may be recommended to monitor for any abnormalities. Patients with preexisting liver conditions may require closer monitoring.
Benefits Of Cardiorostin FB 160mg/10mg Tablet
- Combination lipid lowering medication .
- Manages high cholesterol levels .
- Reduces triglycerides and LDL cholesterol .
- May improve overall cardiovascular health.
Side Effects Of Cardiorostin FB 160mg/10mg Tablet
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
What If I Missed A Dose Of Cardiorostin FB 160mg/10mg Tablet
Use medicine as you remember to take. If next dose is approaching, skip the missed Dose. Do not double up for the compensation of missed Dose. If you miss dose frequently than consult your Doctor.
Health And Lifestyle
Disease Explanation
A heart attack happens when there is reduced oxygen supply to the heart due to decrease in blood flow which is caused by blockage of blood vessels, ultimately leading to heart muscle damage. Symptoms include sharp chest pain, shortness of breath, and dizziness. It may even lead to death in some cases.
Safety Advice for Cardiorostin FB 160mg/10mg Tablet
- High risk
- Moderate risk
- Safe
Consuming alcohol with it is unsafe.
Not recommended if you’re pregnant, consult your doctor for specific information.
If you’re breastfeeding, consult your doctor before taking this medicine.
Exercise caution when using it in individuals with kidney disease. Adjustments to the dosage may be necessary, so it's important to seek advice from your doctor.
Monitor liver enzymes; potential risk of liver-related issues with this combination.
FAQ's on Cardiorostin FB 160mg/10mg Tablet
What medicines should I avoid while taking Cardiorostin FB Tablet?
Can the use of Cardiorostin FB Tablet cause liver damage?
What are the instructions for the storage and disposal of Cardiorostin FB Tablet?
What lifestyle changes should I adopt while taking Cardiorostin FB Tablet?
Can the use of Cardiorostin FB Tablet cause muscle pain?
Written By
Akriti Agarwal
B. Pharm
Content Updated on
Saturday, 8 June, 2024
